Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 29 results.
User Information
Export Records
  1. 1.   The chromosome 2p21 region harbors a complex genetic architecture for association with risk for renal cell carcinoma
  2. Han, S. S.; Yeager, M.; Moore, L. E.; Wei, M. H.; Pfeiffer, R.; Toure, O.; Purdue, M. P.; Johansson, M.; Scelo, G.; Chung, C. C.; Gaborieau, V.; Zaridze, D.; Schwartz, K.; Szeszenia-Dabrowska, N.; Davis, F.; Bencko, V.; Colt, J. S.; Janout, V.; Matveev, V.; Foretova, L.; Mates, D.; Navratilova, M.; Boffetta, P.; Berg, C. D.; Grubb, R. L.; Stevens, V. L.; Thun, M. J.; Diver, W. R.; Gapstur, S. M.; Albanes, D.; Weinstein, S. J.; Virtamo, J.; Burdett, L.; Brisuda, A.; McKay, J. D.; Fraumeni, J. F.; Chatterjee, N.; Rosenberg, P. S.; Rothman, N.; Brennan, P.; Chow, W. H.; Tucker, M. A.; Chanock, S. J.; Toro, J. R.
  3. Human Molecular Genetics. 2012, Mar; 21(5): 1190-1200.
  1. 2.   Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3
  2. Purdue, M. P.; Johansson, M.; Zelenika, D.; Toro, J. R.; Scelo, G.; Moore, L. E.; Prokhortchouk, E.; Wu, X. F.; Kiemeney, L. A.; Gaborieau, V.; Jacobs, K. B.; Chow, W. H.; Zaridze, D.; Matveev, V.; Lubinski, J.; Trubicka, J.; Szeszenia-Dabrowska, N.; Lissowska, J.; Rudnai, P.; Fabianova, E.; Bucur, A.; Bencko, V.; Foretova, L.; Janout, V.; Boffetta, P.; Colt, J. S.; Davis, F. G.; Schwartz, K. L.; Banks, R. E.; Selby, P. J.; Harnden, P.; Berg, C. D.; Hsing, A. W.; Grubb, R. L.; Boeing, H.; Vineis, P.; Clavel-Chapelon, F.; Palli, D.; Tumino, R.; Krogh, V.; Panico, S.; Duell, E. J.; Quiros, J. R.; Sanchez, M. J.; Navarro, C.; Ardanaz, E.; Dorronsoro, M.; Khaw, K. T.; Allen, N. E.; Bueno-De-Mesquita, H. B.; Peeters, P. H. M.; Trichopoulos, D.; Linseisen, J.; Ljungberg, B.; Overvad, K.; Tjonnel, A.; Romieu, I.; Riboli, E.; Mukeria, A.; Shangina, O.; Stevens, V. L.; Thun, M. J.; Diver, W. R.; Gapstur, S. M.; Pharoah, P. D.; Easton, D. F.; Albanes, D.; Weinstein, S. J.; Virtamo, J.; Vatten, L.; Hveem, K.; Njolstad, I.; Tell, G. S.; Stoltenberg, C.; Kumar, R.; Koppova, K.; Cussenot, O.; Benhamou, S.; Oosterwijk, E.; Vermeulen, S. H.; Aben, K. K. H.; van der Marel, S. L.; Ye, Y. Q.; Wood, C. G.; Pu, X.; Mazur, A. M.; Boulygina, E. S.; Chekanov, N. N.; Foglio, M.; Lechner, D.; Gut, I.; Heath, S.; Blanche, H.; Hutchinson, A.; Thomas, G.; Wang, Z. M.; Yeager, M.; Fraumeni, J. F.; Skryabin, K. G.; McKay, J. D.; Rothman, N.; Chanock, S. J.; Lathrop, M.; Brennan, P.
  3. Nature Genetics. 2011, Jan; 43(1): 60-U83.
  1. 3.   Biological Validation of Increased Schizophrenia Risk With NRG1, ERBB4, and AKT1 Epistasis via Functional Neuroimaging in Healthy Controls
  2. Nicodemus, K. K.; Law, A. J.; Radulescu, E.; Luna, A.; Kolachana, B.; Vakkalanka, R.; Rujescu, D.; Giegling, I.; Straub, R. E.; McGee, K.; Gold, B.; Dean, M.; Muglia, P.; Callicott, J. H.; Tan, H. Y.; Weinberger, D. R.
  3. Archives of General Psychiatry. 2010, Oct; 67(10): 991-1001.
  1. 4.   Interleukin-7 Regulates Bim Proapoptotic Activity in Peripheral T-Cell Survival
  2. Li, W. Q.; Guszczynski, T.; Hixon, J. A.; Durum, S. K.
  3. Molecular and Cellular Biology. 2010, Feb; 30(3): 590-600.
  1. 5.   The RNA-binding Motif Protein 15B (RBM15B/OTT3) Acts as Cofactor of the Nuclear Export Receptor NXF1
  2. Uranishi, H.; Zolotukhin, A. S.; Lindtner, S.; Warming, S.; Zhang, G. M.; Bear, J.; Copeland, N. G.; Jenkins, N. A.; Pavlakis, G. N.; Felber, B. K.
  3. Journal of Biological Chemistry. 2009 284(38): 26106-26116.
  1. 6.   TREM-like transcript-1 protects against inflammation-associated hemorrhage by facilitating platelet aggregation in mice and humans
  2. Washington, A. V.; Gibot, S.; Acevedo, I.; Gattis, J.; Quigley, L.; Feltz, R.; De La Mota, A.; Schubert, R. L.; Gomez-Rodriguez, J.; Cheng, J.; Dutra, A.; Pak, E.; Chertov, O.; Rivera, L.; Morales, J.; Lubkowski, J.; Hunter, R.; Schwartzberg, P. L.
  3. Journal of Clinical Investigation. 2009 119(6): 1489-1501.
  1. 7.   DNA hypomethylation caused by Lsh deletion promotes erythroleukemia development
  2. Fan, T.; Schmidtmann, A.; Xi, S.; Briones, V.; Zhu, H. M.; Suh, H. C.; Gooya, J.; Keller, J. R.; Xu, H.; Roayaei, J.; Anver, M.; Ruscetti, S.; Muegge, K.
  3. Epigenetics. 2008 3(3): 134-142.
  1. 8.   Differential roles of C/EBP beta regulatory domains in specifviuy MCP-1 and IL-6 transcription
  2. Spooner, C. J.; Guo, X. R.; Johnson, P. F.; Schwartz, R. C.
  3. Molecular Immunology. 2007, Feb; 44(6): 1384-1392.
  1. 9.   Itch genetically interacts with Notch1 in a mouse autoimmune disease model
  2. Matesic, L. E.; Haines, D. C.; Copeland, N. G.; Jenkins, N. A.
  3. Human Molecular Genetics. 2006, Dec; 15(24): 3485-3497.
  1. 10.   RAP uses a histidine switch to regulate its interaction with LRP in the ER and Golgi
  2. Lee, D.; Walsh, J. D.; Mikhailenko, I.; Yu, P.; Migliorini, M.; Wu, Y. B.; Krueger, S.; Curtis, J. E.; Harris, B.; Lockett, S.; Blacklow, S. C.; Strickl, D. K.; Wang, Y. X.
  3. Molecular Cell. 2006, MAY 5; 22(3): 423-430.
  1. 11.   Distribution of Epstein-Barr viral load in serum of individuals from nasopharyngeal carcinoma high-risk families in Taiwan
  2. Yang, X. H. R.; Goldstein, A. M.; Chen, C. J.; Rabkin, C. S.; Chen, J. Y.; Cheng, Y. J.; Hsu, W. L.; Sun, B.; Diehl, S. R.; Liu, M. Y.; Walters, M.; Shao, W.; Ortiz-Conde, B. A.; Whitby, D.; Elmore, S. H.; Gulley, M. L.; Hildesheim, A.
  3. International Journal of Cancer. 2006, MAR 1; 118(3): 780-784.
  1. 12.   Structural insight into the mechanism of double-stranded RNA processing by ribonuclease III
  2. Gan, J. H.; Tropea, J. E.; Austin, B. P.; Court, D. L.; Waugh, D. S.; Ji, X. H.
  3. Cell. 2006, JAN 27; 124(2): 355-366.
  1. 13.   Lsh is involved in de novo methylation of DNA
  2. Zhu, H. M.; Geiman, T. M.; Xi, S. C.; Jiang, Q.; Schmidtmann, A.; Chen, T. P.; Li, E.; Muegge, K.
  3. Embo Journal. 2006, JAN 25; 25(2): 335-345.
  1. 14.   Combining proteasome inhibition with TNF-related apoptosis-inducing ligand (Apo2L/TRAIL) for cancer therapy
  2. Sayers, T. J.; Murphy, W. J.
  3. Cancer Immunology Immunotherapy. 2006, JAN; 55(1): 76-84.
  1. 15.   Factors associated with patients' perceptions of health care providers' communication behavior
  2. Rutten, L. J. F.; Augustson, E.; Wanke, K.
  3. Journal of Health Communication. 2006 11: 135-146.
  1. 16.   The immunopharmacological properties of transforming growth factor beta
  2. Le, Y. Y.; Yu, X. J.; Ruan, L. F.; Wang, O. M.; Qi, D. F.; Zhu, J. J.; Lu, X. F.; Kong, Y.; Cai, K.; Pang, S. S.; Shi, X. L.; Wang, J. M.
  3. International Immunopharmacology. 2005, DEC; 5(13-14): 1771-1782.
  1. 17.   Plasmid partition system of the P1par family from the pWR100 virulence plasmid of Shigella flexneri
  2. Sergueev, K.; Dabrazhynetskaya, A.; Austin, S.
  3. Journal of Bacteriology. 2005, MAY; 187(10): 3369-3373.
  1. 18.   Lsh controls silencing of the imprinted Cdkn1c gene
  2. Fan, T.; Hagan, J. P.; Kozlov, S. V.; Stewart, C. L.; Muegge, K.
  3. Development. 2005, FEB; 132(4): 635-644.
  1. 19.   Lyn contributes to regulation of multiple Kit-dependent signaling pathways in murine bone marrow mast cells
  2. Shivakrupa, R.; Linnekin, D.
  3. Cellular Signalling. 2005, JAN; 17(1): 103-109.
  1. 20.   Substrate-induced conformational changes in glycosyltransferases
  2. Qasba, P. K.; Ramakrishnan, B.; Boeggeman, E.
  3. Trends in Biochemical Sciences. 2005, JAN; 30(1): 53-62.
  1. 21.   Expression and evaluation of RING finger proteins
  2. Yang, Y. L.; Lorick, K. L.; Jensen, J. P.; Weissman, A. M.
  3. Methods in Enzymology. 2005; 398 : 103-112.
  1. 22.   Single haplotype analysis demonstrates rapid evolution of the killer immunoglobulin-like receptor (KIR) loci in primates
  2. Sambrook, J. G.; Bashirova, A.; Palmer, S.; Sims, S.; Trowsdale, J.; bi-Rached, L.; Parham, P.; Carrington, M.; Beck, S.
  3. Genome Research. 2005, JAN; 15(1): 25-35.
  1. 23.   Birt-Hogg-Dube syndrome, a genodermatosis that increases risk for renal carcinoma
  2. Schmidt, L. S.
  3. Current Molecular Medicine. 2004, DEC; 4(8): 877-885.
  1. 24.   Tumor endothelial markers: new targets for cancer therapy
  2. Nanda, A.; St Croix, B.
  3. Current Opinion in Oncology. 2004, JAN; 16(1): 44-49.
  1. 25.   Inhibition of growth by p205: A nuclear protein and putative tumor suppressor expressed during myeloid cell differentiation
  2. Dermott, J. M.; Gooya, J. M.; Asefa, B.; Weiler, S. R.; Smith, M.; Keller, J. R.
  3. Stem Cells. 2004 22(5): 832-848.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel